Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can fortified foods help Zimbabwe's children grow stronger?

NCT ID NCT04874688

Disease control Sponsor: Queen Mary University of London Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding extra nutrient-rich foods to infants' diets can help them get enough energy and nutrients to prevent stunting. 192 infants in rural Zimbabwe received either standard fortified supplements or an enhanced mix including orange maize, beans, moringa, and egg powder. Researchers measured their nutrient intake, growth, and blood health at 9 months of age.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Small-quantity lipid-based nutrient supplement (SQ-LNS) plus fortified foods (orange maize, sugar beans, moringa, egg powder)
What this could lead to
If successful, this could show a practical way to improve nutrition and reduce stunting in young children in resource-limited settings.
What could go wrong
This is a small, early-stage trial focused on dietary intake, not long-term health outcomes. Results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

192 people

The number who actually took part.

Started

Apr 2021

Finished

Feb 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 6 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 5-6 months * Planning to live in the study area for the duration of the trial Exclusion Criteria: * Severe infant disability that interferes with feeding * Known allergy to peanuts or eggs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stunting are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hereditary endocrine growth disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stunting

Contacts and locations

Locations

  • Zvitambo Institute for Maternal and Child Health Research

    Harare, Zimbabwe

More trials for these conditions

Other studies related to the condition(s) this trial covers.